Research Papers / Publications:
1. Garg, S., Jaiswal, A., Sarkhel, Samuel J., Singh J., & Singh S. Modeling hexavalent chromium removal from aqueous systems using a fixed bed of immobilized bacteria and zero-valent iron nanoparticles. 3 Biotech 15, 372 (2025). https://doi.org/10.1007/s13205-025-04547-4 (IF 2.9)
2. Gund V, Sharma S, Chandan S, Garg S, Singh S. Identification of non-synonymous SNPs affecting structure and function of MLH1 and NBN proteins: a computational approach. J Appl Genet. 2025. doi: 10.1007/s13353-025-00968-2.
3. Kaur, I., Kansal, H., Singh, S., Singh, N., & Sharma, S. (2024). Association of hTERT MNS16A polymorphism with clinical outcomes of North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Clinical and Translational Oncology, 1-15. (IF-2.8) DOI: 10.1007/s12094-024-03800-1
4. Singh, S., Singh, N., Sharma, S., “Genetic polymorphism in mismatch repair genes as a modulator of lung cancer risk in North Indians undergoing platinum-based doublet chemotherapy: A multi-factor analytic strategy” Nucleosides, Nucleotides & Nucleic Acids (Under review) (IF-1.167)
5. S S Kirthiga; Patil, S; Singh, S, Devi, V; Joga, R; Dushantrao, S; Dwivedi, F; Kumar, G; Jindal, D; Singh, C; Dhamija, I and Kumar, S. (2024) Enhancing Cancer Immunotherapy: Exploring Strategies to Target the PD-1/PD-L1 Axis and Analyzing the Associated Patent, Regulatory, and Clinical Trial Landscape. European Journal of Pharmaceutics and Biopharmaceutics 114323. (IF 4.38) DOI: 10.1016/j.ejpb.2024.114323
6. Singh, S., Singh, N., Gupta, P. S. S., Panda, S. K., Dhamija, I., Nathiya, D., & Sharma, S. (2024). Assessing the impact of MSH3 and MSH6 polymorphisms on lung cancer risk in North Indian patients undergoing platinum chemotherapy through molecular dynamics simulation. Scientific Reports, 14(1), 16164. (IF 3.8) DOI: 10.1038/s41598-024-67090-x
7. Singh, S., Baranwal, M., Singh, N., Sharma, S., “MSH3 and MSH6 gene polymorphisms: Association with lung cancer susceptibility and prognostic value in patients with NSCLC undergoing platinum-based chemotherapy” Journal of Clinical Oncology 41, no. 16_suppl (June 01, 2023) 9031-9031. DOI: 10.1200/JCO.2023.41.16_suppl.9031 (IF 50.717)
8. Yadav, H., Pandit, D., Singh, S., Sharma, P., Garg, K., Girdhar, N., Sharma, K., Chopra, V., Chopra, S and Sharma, S. (2023) GST polymorphism as a predictive biomarker for modulating the susceptibility to Chronic Obstructive Pulmonary Disease: A North Indian study. Experimental Physiology, 1–10. DOI: 10.1113/EP091339 (IF 2.7)
9. Singh, S., Sharma, S., Baranwal, M., and Kataria, S. (2023) Understanding immune checkpoints and PD-1/PD-L1 mediated immune resistance towards tumor immunotherapy. 3Biotech. 13, 411 DOI: 10.1007/s13205-023-03826-2. (IF 2.8)
10. Singh, S., Gupta, A., Singh, N., Sengupta, P. S., Panda, S. K., & Sharma, S. (2023). Genotyping, in silico screening and molecular dynamics simulation of SNPs of MGMT and ERCC1 gene in lung cancer patients treated with platinum-based doublet chemotherapy. Journal of Biomolecular Structure and Dynamics. 1-20 DOI: 10.1080/07391102.2023.2261052 (IF 4.5)
11. Singh, S., Singh, N., Baranwal, M., & Sharma, S. (2023). Association of MLH1-93G> A polymorphisms toward lung cancer susceptibility and its association with clinical outcome in North Indian patients treated with platinum-based chemotherapy. Journal of Cancer Research and Therapeutics, 19(Suppl 1), S397-S403. DOI: 10.4103/jcrt.jcrt_465_21 (IF- 1.331)
12. Singh, S., Sharma, S., Lawania, S., & Singh, N. (2023). Single-nucleotide polymorphisms of nucleotide excision repair genes and their association with overall survival in North Indian lung cancer patients treated with platinum-based doublet chemotherapy. Journal of Cancer Research and Therapeutics, 19(2), 408-419. DOI: 10.4103/jcrt.jcrt_2062_21 (IF-1.331)
13. Singh, S., Singh, N., & Sharma, S., (2022) “Genetic polymorphisms in the Mismatch Repair Pathway (MMR) contribute to hematological and gastrointestinal toxicity in North Indian lung cancer patients treated with platinum-based chemotherapy” Journal of Biochemical and Molecular Toxicology. 36(11), e23183. DOI: 10.1002/jbt.23183 (IF-3.568)
14. Singh, S., Singh, N., Baranwal, M., & Sharma, S. (2022). Structural, functional analysis and association of MSH6 rs1800932, rs1042821 polymorphisms with clinical outcome in North Indian lung cancer patients treated with platinum-based doublet chemotherapy. The American Journal of the Medical Sciences. 364(6), 735-745. DOI: 10.1016/j.amjms.2022.07.005 (IF-3.462)
15. Singh, S., Sharma, S., & Baranwal, M. (2022). Identification of SNPs in hMSH3/MSH6 interaction domain affecting the structure and function of MSH2 protein. Biotechnology and Applied Biochemistry, 69(6), 2454-2465. DOI: 10.1002/bab.2295 (IF-2.724)
16. Singh, S., Baranwal, M., Singh, N., & Sharma, S., (2022) “Polymorphisms in the MSH2 gene predict poor survival of North Indian lung cancer patients undergoing chemotherapy. Biomarkers in Medicine, 16(2), 69-82. DOI: 10.2217/bmm-2021-0565 (IF-2.498)
17. Kashyap, S., Kumar, V., Abraham, S., Umrao, S., Singh, S., Kamath, A., Rajala MS, Srivastava, A., and Saxena, P.*(2017) “Microwave Reduced Graphene Oxide as Efficient NIR Photothermal Agent” Austin Journal of Biosensors & Bioelectronics, , Vol 3, Issue 1, (1026; 1-5).
18. Singh, S., Sharma, M., Kumar, S., & Gowal, D. (2015). Standardization of serum neutralization assay of Japanese encephalitis virus (Nakayama NIH strain) on BHK-21 (Cl-13) cell line. Acta virologica, 59(3), 234-239. DOI: 10.4149/av_2015_03_234 (IF 1.82)
Read More
